David A. Siegel Sqz Biotechnologies CO Transaction History

Two Sigma Advisers, LP

  • $42.5 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.77 - $5.0 $58,170 - $105,000
-21,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.01 - $10.42 $9,624 - $25,008
2,400 Added 12.9%
21,000 $101,000
Q4 2021

Feb 14, 2022
BUY
$8.93 - $14.85 $166,098 - $276,210
18,600 New
18,600 $166,000

Others Institutions Holding SQZ

# of Institutions
3
Shares Held
1.47M
Call Options Held
0
Put Options Held
0
View Full List

About SQZ Biotechnologies Co

SQZ Quotes by TradingView
  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email